UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035006
Receipt number R000039917
Scientific Title Clinical study to evaluate acceptabilities of minitablets in children
Date of disclosure of the study information 2018/11/26
Last modified on 2019/05/27 15:08:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study to evaluate acceptabilities of minitablets in children

Acronym

Clinical study to evaluate acceptabilities of minitablets in children

Scientific Title

Clinical study to evaluate acceptabilities of minitablets in children

Scientific Title:Acronym

Clinical study to evaluate acceptabilities of minitablets in children

Region

Japan


Condition

Condition

Children undergoing internal treatment

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate acceptabilities of minitablet(placebo, diameter 2mm) for children.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The ability of swallowing the medicine

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine Other

Interventions/Control_1

ingestion of Minitablet

Interventions/Control_2

ingestion of Syrup

Interventions/Control_3

ingestion of Granule

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

2 years-old <=

Age-upper limit

8 years-old >=

Gender

Male and Female

Key inclusion criteria

1) The patients have a chronic disease,and need taking medicine routinely.
2) Age between 2 - 8 years old at the time of informed consent.
3) The patient without swallowing disorder.
4) The patients who can be obtained informed consent by their guardians.

Key exclusion criteria

1) Any drug allergy.
2) Subjects who are inadequate for enrollment judged by the investigators

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Noriko
Middle name
Last name Noriko

Organization

Showa University

Division name

Department of Pharmacology Clinical Pharmacology School of Medicine

Zip code

157-8577

Address

6-11-11 Kitakarasuyama Setagaya-ku Tokyo

TEL

03-3300-5254

Email

n.hida@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Tsutomu
Middle name
Last name Harada

Organization

Showa University

Division name

Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy

Zip code

1758577

Address

1-5-8 Hatanodai Shinagawa-ku Tokyo

TEL

03-3784-8203

Homepage URL


Email

tharada@pharm.showa-u.ac.jp


Sponsor or person

Institute

Showa University
Department of Pharmacology Clinical Pharmacology School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Pediatrics, Showa University School of Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa Univ. IRB

Address

1-5-8, Hatanodai, Shinagawaw-ku, Tokyo

Tel

03-3784-8129

Email

m-rinri@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 26 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

65

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 11 Month 22 Day

Date of IRB

2018 Year 11 Month 29 Day

Anticipated trial start date

2019 Year 01 Month 04 Day

Last follow-up date

2019 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 11 Month 26 Day

Last modified on

2019 Year 05 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039917


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name